NCT05296421View on ClinicalTrials.gov

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

July 1, 2026

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

OTHER

Uniformly-labeled [13C]glucose

Given IV

Trial Locations (2)

07039

RECRUITING

Cooperman Barnabas Medical Center (Saint Barnabas Medical Center), Livingston

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Rutgers, The State University of New Jersey

OTHER